Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the penis

Anticancer Research

Volumn 27, Issue 4 B, 2007, Pages 2167-2174

  Papadopoulos, O ^a   Betsi, E ^a   Tsakistou, G ^b   Fangoulis, M ^a   Kouvatseas, G ^c   Anagnostakis, D ^b   Kouvidou, Ch ^b,d  

^a ANDREAS SYGROS HOSPITAL   (Greece)

^b IASO GENERAL HOSPITAL   (Greece)

^c ATHENS UNIVERSITY OF ECONOMICS AND BUSINESS   (Greece)

^d NONE   (Greece)

Author keywords

Cyclin D1; Ki 67; Penis; Squamous cell carcinoma

Indexed keywords

CYCLIN D1; FORMALDEHYDE; KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67; PARAFFIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RELAPSE; CANCER SURVIVAL; CELL CYCLE; CLINICAL ARTICLE; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; CORRELATION ANALYSIS; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LICHEN SCLEROSUS ET ATROPHICUS; MALE; OUTCOME ASSESSMENT; PENIS CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; TUMOR DIFFERENTIATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CYCLIN D1; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM STAGING; PENILE NEOPLASMS; PROGNOSIS;

EID: 34547806747     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Rippentrop JM, Joslyn SA and Konety BR: Squamous cell carcinoma of the penis. Evaluation of data from surveillance, epidemiology, and end results program. Cancer 101: 1357-1363, 2004.
2. Cordon-Cardo C: Mutations of cell regulators. Am J Pathol 147: 545-560, 1995.
3. Sherr CJ: Mammalian G1 cyclins. Cell 73: 1059-1065, 1993.
4. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81: 323-330, 1995.
5. Motokura T, Bloom T, Kim HG, Jupper H, Ruderman JV, Kronenberg HM et al: A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 350: 512-515, 1991.
6. Pines J and Hunter T: Cyclins and cancer II: cyclin D1 and CDK inhibitors come of age. Cell 79: 573-582, 1994.
7. Matsumoto M, Furihata M, Ishikawa T, Ohtsuki Y and Ogoshi S: Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma. Br J Cancer 80(1/2): 256-261, 1999.
8. Sarbia M, Stahl M, Fink U, Heep H, Dutkowski P, Willers R et al: Prognostic significance of cyclin D1 in eosophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalities. Int J Cancer (Pred Oncol) 84: 86-91, 1999.
9. Berenson JR, Yang J and Mickel RA: Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas. Oncogene 4: 1111-1116, 1989.
10. Namazie A, Alavi S, Olopade OI, Pauletti G, Aghamohammadi N, Aghamohammadi M et al: Cyclin D1 amplification and p16(MTSI/CDKAI) deletion correlate with poor prognosis in head and neck tumours. Laryngoscope 112: 472-481, 2002.
11. Zhang YJ, Jiang W, Chen CJ, Lee CS, Kahn SM, Santella RM et al: Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun 196: 1010-1016, 1993.
12. Arber N, Hibshoosh H, Moss SF, Sutter T, Zhang Y, Begg M et al: Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastrenterology 110: 669-674, 1996.
13. Weinstat-Saslow D, Merino MJ, Manrow RE, Lawrence JA, Bluth RF, Wittenbel KD et al: Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nature Med 1: 1257-1260, 1995.
14. Michalides R, Hageman P, van Tinteren H, Houben L, Wientjens E, Klompmaker R et al: A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer 73: 728-734, 1996.
15. Quelle DE, Ashmum RA, Shurtleff SA, Kato JY, Bar-Sagi D, Roussel MF et al: Overexpression of mouse D type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 7: 1559-1571, 1993.
16. Resnitzky D, Gossen M, Bujard H and Reed S: Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 14: 1669-1679, 1994.
17. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U and Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by a monoclinal antibody Ki-67. J Immunol 133: 1710-1715, 1984.
18. Bellacosa A, Almadori G, Cavallo S, Cadoni G, Galli J, Ferrandina G et al: Cyclin D1 amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications. Clin Cancer Res 2: 175-180, 1996.
19. Esposito V, Baldi A, De Luca A, Tonini G, Vincenzi B, Santini D et al: Cell cycle related proteins as prognostic parameters in radically resected non-small cell lung cancer. J Clin Pathol 58: 734-739, 2005.
20. Betticher DC, Heighway J, Hasleton PS, Altermatt HJ, Ryder WD, Cerny T et al: Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. Br J Cancer 73: 294-300, 1996.
21. Shiraki M, Odajima T, Ikeda T, Sasaki A, Satoh M, Yamaguchi A et al: Combined expression of p53, cyclin D1 and epidermal growth factor receptor improves estimation of prognosis in curatively resected oral cancer. Modern Pathology 18: 1482-1489, 2005.
22. Van Diest PJ, Michaelides RJAM, Jannink I et al: Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value. Am J Pathol 150: 705-711, 1997.
23. Gillett C, Smith P, Gregory W, Richards M, Millis R, Peters G et al: Cyclin D1 and prognosis in human breast cancer. Int J Cancer 69: 92-99, 1996.
24. Niehans GA, Kratzke RA, Froberg MK, Aeppli DM, Nguyen PL and Geradts J: G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder. Br J Cancer 80(8): 1175-1184, 1999.
25. Mishina T, Dosaka-Akita H, Kinoshita I, Hommura F, Morikawa T, Katoh H et al: Cyclin D1 expression in non-small cell lung cancers: its association with the altered p53 expression, cell proliferation and clinical outcome. Br J Cancer 80: 1289-1295, 1999.
26. Nishio M, Koshikawa T, Yatabe Y, Kuroishi T, Suyama M, Nagatake M et al: Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers. Clin Cancer Res 3: 1051-1058, 1997.
27. Marhin WW, Hei YJ, Chen S, Jiang Z, Gallie BL, Phillips RA et al: Loss of Rb and Myc activation co-operate to suppress cyclin D1 and contribute to transformation. Oncogene 12: 43-52, 1996.
28. Kouvidou Ch, Stefanaki K, Dai Y, Tzardi M, Koutsoubi K, Darivianaki K et al: P21/waf1 protein expression in nasopharyngeal carcinoma. Comparative study with PCNA, p53 and mdm-2 protein expression. Anticancer Res 17: 2615-2620, 1997.
29. Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C et al: Amplification of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 54: 1812-1817, 1994.
30. Myo K, Uzawa N, Miyamoto R, Sonoda I, Yuki Y and Amagasa T: Cyclin D1 gene numerical aberration is a predictive marker for occult cervical lymph node metastasis in TNM stage I and II squamous cell carcinoma of the oral cavity. Cancer 104: 2709-2716, 2005.
31. Lamb J, Ramaswamy S and Ford HL: A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114: 323-334, 2003.
32. Brambilla E, Moro D, Gazzeri S and Brambilla C: Alterations of expression of Rb, p16 and cyclin D1 in non-small cell lung carcinoma and their clinical significance. J Pathol 188: 351-360, 1999.
33. Shiohara S, Shiozawa T, Miyamoto T, Feng YZ, Kashima H, Kurai M et al: Expression of cyclins, p53, and Ki-67 in cervical squamous cell carcinomas: overexpression of cyclin A is a poor prognostic factor in stage Ib and II disease. Virchows Arch 446: 626-633, 2005.
34. Maoxin W, Putti T and Bhuiya TA: Comparative study in the expression of p53, EGFR, TGF-a, and cyclin D1 in verrucous carcinoma, verrucous hyperplasia and squamous cell carcinoma of head and neck region. Appl Immunohistochem Mol Morphol 10(4): 351-356, 2002.
35. Jares P, Rey MJ, Fernandez PL, Campo E, Nadal A, Muñoz M et al: Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: correlation with the tumour proliferation and oestrogen receptor status. J Pathol 182: 160-166, 1997.
36. Bartkova J, Lukas J, Muller H, Lützhøft D, Strauss M and Bartek J: Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 57: 353-361, 1994.
37. Zhan S-Y, Caamano J, Cooper F, Guo X and Klein-Szanto AJ: Immunohistochemistry of cyclin D1 in human breast cancer. Am J Clin Pathol 102: 695-698, 1994.
38. Masuda M, Hirakawa N, Nakashima T, Kuratomi Y and Komiyama S: Cyclin D1 overexpression in primary hypopharyngeal carcinomas. Cancer 78: 390-395, 1996.
39. Berdjis N, Meye A, Nippgen D, Dittert D, Hakenberg O, Baretton GB et al: Expression of Ki-67 in squamous carcinoma of the penis. BJU International 96: 146-148, 2005.
40. Lantsov D, Meirmanov S, Nakashima M, Kondo H, Saenko V, Naruke Y et al: Cyclin D1 overexpression in thyroid papillary microcarcinoma: its association with the tumour size and aberrant β-catenin expression. Histopathology 47: 248-256, 2005.
41. Shoker BS, Jarvis C, Davies MP A, Iqbal M, Sibson DR and Sloane JP: Immunodetectable cyclin D1 is associated with oestrogen receptor but not Ki-67 in normal, cancerous and precancerous breast lesions. Br J Cancer 84(8): 1064-1069, 2001.
42. Sgambato A, Migaldi M, Faraglia B, Aloysio GD, Ferrari P, Ardito R et al: Cyclin D1 expression in papillary superficial bladder cancer: Its association with other cell cycle-associated proteins, cell proliferation and clinical outcome. Int J Cancer 97: 671-678, 2002.
43. Robles AI and Conti CJ: Early overexpression of cyclin D1 protein in mouse skin carcinogenesis. Carcinogenesis 16: 781-786, 1995.
44. Fukami-Kobayashi J and Mitsui Y: The regulation of cyclin D1 expression in senescent human fibroblasts. Exp Cell Res 241: 435-444, 1998.